Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04342494 · ClinicalTrials.gov registry record · NA

Providing Mental Health Precision Treatment

A NA study of Depression and Anxiety, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
2,118
Enrollment target
1
Study location

NCT04342494 is a NA study of Depression and Anxiety that has completed, run by University of Michigan. The registered enrollment target is 2,118 participants, above the 783-participant average among 679 other Depression trials with a reported enrollment target (170% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04342494, a NA study of Depression and Anxiety, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
2,118 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments, and to understand which patients receive the most benefit.

Interventions

  • BEHAVIORAL Enhanced Feedback + Standard Feedback
  • DEVICE Headspace app + Standard Feedback
  • DEVICE Headspace app + Enhanced Feedback + Standard Feedback
  • DEVICE SilverCloud + Standard Feedback
  • DEVICE SilverCloud app +Enhanced Feedback +Standard Feedback

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 2,118 participants
Start Date 2020-05-13
Est. Completion 2023-02-22
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04342494

The ClinicalTrials.gov registry entry for NCT04342494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,118 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 783-participant average among 679 other Depression trials with a reported enrollment target (170% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which Enhanced Feedback + Standard Feedback is the first listed.

NCT04342494 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04342494 about?

NCT04342494 is a clinical study titled "Providing Mental Health Precision Treatment". This research study is being conducted to understand if patients benefit from mobile health interventions while waiting for in-clinic mental health treatments, and to understand which patients receive the most benefit.

What is the current status of trial NCT04342494?

This trial is currently completed. It is a NA study. The enrollment target is 2,118 participants. The study started on 2020-05-13. Estimated completion is 2023-02-22.

What conditions does trial NCT04342494 study?

This clinical trial studies the following conditions: Depression, Anxiety, Sleep Disturbance, Addiction.

What interventions are being tested in trial NCT04342494?

The interventions under investigation include: Enhanced Feedback + Standard Feedback (BEHAVIORAL), Headspace app + Standard Feedback (DEVICE), Headspace app + Enhanced Feedback + Standard Feedback (DEVICE), SilverCloud + Standard Feedback (DEVICE), SilverCloud app +Enhanced Feedback +Standard Feedback (DEVICE).

Who is sponsoring clinical trial NCT04342494?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04342494 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.